“I was informed that Thread Robotics will be closed by the end of the month.” Oma Fertility Lab Director, Dr. Barry Behr, confirmed in a phone call with Inside Reproductive Health.

“They are moving quickly to try to sell the clinics and labs”. Dr. Behr said he did not know which companies might buy the clinics nor did he say if the company was filing for bankruptcy.

In an email to Inside Reproductive Health on July 21, Oma Fertility CEO, Gurjeet Singh said “I can confirm that we are not filing for bankruptcy. I’ve heard the rumor as well and it is unfortunate.”

Mr. Singh did not respond to other requests for comment about the future of the company.

Oma Fertility employees who announced their layoffs on LinkedIn said the layoffs began on Tuesday, August 1, but no official number of eliminated posts has been released by the company. One Oma Fertility employee, who wished to remain unidentified, said that office and corporate staff had been laid off.

Both the employee and Dr. Behr said that no official announcement about layoffs has been made to the employees.

Oma Fertility launched in 2022 with the raising of $37.5 million in debt and venture funding. On May 31, Oma Fertility opened a new clinic in Atlanta. Oma opened the doors of its Atlanta location in the same month as it opened new locations in St. Louis and New York City.

Singh, told Inside Reproductive Health that Oma had been practicing in the three cities since 2022. Singh said he rented a space in each city for about six to nine months while the permanent locations were being built.

Dr. Behr said he did not believe layoffs were planned for lab and clinical personnel. “The parent company will pay my check until the end of the month. As far as I know the lab and clinic staff are going to keep working. They need them to be valuable to a potential buyer”.

Larkin out, Reymann in as Top Boss of First Fertility

BY: STAFF

Inside Reproductive Health obtained an email sent by a First Fertility executive that said that CEO Derek Larkin stepped down as CEO to pursue another opportunity.

The executive said that Larkin’s last day was Monday July 31 and that Cara Reymann will take over as CEO on September 6. Ms. Reymann was previously president of Fertilitas for one year and held Market President and other roles at Capital Digestive Care for 12 years, according to her LinkedIn profile.

The email did not specify the role for which Larkin left. Inside Reproductive Health has not yet reached out to Larkin, Reymann, or First Fertility for comment.

The themes reported in this publication are those of the news. They do not reflect the views of Inside Reproductive Health.

All external links active as of 8/2/23.

External links are being provided as a convenience and for informational purposes only; they do not constitute an endorsement or an approval by Fertility Bridge or Inside Reproductive Health of any of the products, services or opinions of the corporation or organization or individual. Neither Fertility Bridge nor Inside Reproductive Health bears responsibility for the accuracy, legality or content of the external site or for that of subsequent links. Contact the external site for answers to questions regarding its content.